Global Neurodiagnostics Market worth USD 8.8 Billion by 2024, at a CAGR -7.7%

Publication Month: Jan 2020 | No. of Pages: 127 Published By: Reports Intellect
Single User License: US $ 3500
Corporate User License: US $ 6500

Market Overview

The Global Neurodiagnostics market size is expected to gain market growth in the forecast period of 2019 to 2024, with a CAGR of 7.7% in the forecast period of 2019 to 2024 and will expect to reach USD 8.8 billion by 2024, from USD 6.2 billion in 2019. The Neurodiagnostics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation

Neurodiagnostics market is split by Product, by Condition, and by End User. For the period 2016-2024, the growth among segments provides accurate calculations and forecasts for sales by Product, by Condition and by End User in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Product, Neurodiagnostics market has been segmented into Diagnostic and Imaging Systems (Electroencephalogram (EEG), Electromyography (EMG), Magnetic Resonance Imaging (MRI) Systems, Computed Tomography Scanner (CT), Magnetoencephalogram (MEG), Position Emisson Tomography (PET), Angiography System, etc.), Clinical Testing Instruments (PCR, Next Generation Sequence, Sanger Sequencing, etc), Reagents & Consumables (Media & Sera, Solvents, Enzymes, Protein & Peptides, Probes, Buffers, Antibodies, etc)

By Condition, Neurodiagnostics market has been segmented into Neuro Degenerative Diseases, Epilepsy, Stroke Headache, Sleep Disorders, etc. 

By End User, Neurodiagnostics market has been segmented into Hospitals & Surgery Centers, Neurology Centers, Ambulatory Care Centers, etc.

Regions and Countries Level Analysis Regional analysis is another highly comprehensive part of the research and analysis study of the global Neurodiagnostics market presented in the report. This section sheds light on the sales growth of different regional and country-level Neurodiagnostics markets. For the historical and forecast period 2016 to 2024, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Neurodiagnostics market.

The report offers in-depth assessment of the growth and other aspects of the Neurodiagnostics market in important countries (regions), including United States, Canada, Mexico, Germany, France, United Kingdom, Russia, Italy, China, Japan, Korea, India, Southeast Asia, Australia, Brazil and Saudi Arabia, etc. It also throws light on the progress of key regional Neurodiagnostics markets such as North America, Europe, Asia-Pacific, South America and Middle East & Africa.

Competitive Landscape and Neurodiagnostics Market Share Analysis Neurodiagnostics competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Neurodiagnostics sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2016-2020, this study provides the Neurodiagnostics sales, revenue and market share for each player covered in this report.

The major players covered in Neurodiagnostics are: GE Healthcare, Siemens Healthineers, Philips Healthcare, Hitachi Ltd., Canon Inc., Lifelines Neuro Company LLC, Natus Medical Incorporated, Hoffman-La Roche AG, FUJIFILM Holdings Corporation, Mitsar Co. Ltd., Advanced Brain Monitoring, Thermo Fisher Scientific Inc., Bio-Rad Laboratories, QIAGEN N.V., Nihon kohden Corporation, ANT Neuro, Fonar Corporation, Fujirebio, DRG Instruments GmbH, Tecan Trading AG, Motion Lab Systems Inc., Rigaku Corporation, Neusoft Medical Systems Co. Ltd., ELMIKO MEDICAL Sp. Z o.o., etc. Among other players domestic and global, Neurodiagnostics market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Reports Intellect Analysts understand competitive strengths and provide competitive analysis for each competitor separately.

The content of the study subjects includes a total of 15 chapters:

Chapter 1, to describe Neurodiagnostics product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top manufacturers of Neurodiagnostics, with price, sales, revenue and global market share of Neurodiagnostics in 2018 and 2019.

Chapter 3, the Neurodiagnostics competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Neurodiagnostics breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2016 to 2020.

Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2020.

Chapter 10, 11, 12, to segment the sales by product, by condition, and by end user with sales market share and growth rate by product, by condition, and by end user, from 2016 to 2020.

Chapter 13, Neurodiagnostics market forecast, by regions, by product, by condition, and by end user, with sales and revenue, from 2021 to 2024.

Chapter 14, 15 and 16, to describe Neurodiagnostics sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Table of Contents

 

1 Market Overview

1.1 Neurodiagnostics Introduction

1.2 Market Analysis by Product 

1.2.1 Overview: Global Neurodiagnostics Revenue by Product: 2016 VS 2019 VS 2024

1.2.2 Diagnostic and Imaging Systems

1.3 Market Analysis by Condition

1.3.1 Overview: Global Neurodiagnostics Revenue by Condition: 2016 VS 2019 VS 2024

1.3.2 Stroke

1.3.3 Epilepsy

1.3.4 Neuro Degenerative Diseases

1.3.5 Headache Disorders                                                                                                                    

1.4 Market Analysis by End User

1.4.1 Overview: Global Neurodiagnostics Revenue by End User: 2016 VS 2019 VS 2024

1.4.2 Neurology Centers

1.4.3 Hospitals & Surgery Centers

1.4.4 Ambulatory Care Centers

1.4.5 Diagnostic Laboratories & Imaging Centers

1.5 Overview of Global Neurodiagnostics Market

1.5.1 Global Neurodiagnostics Market Status and Outlook (2016-2024)

1.5.2 North America (United States, Canada and Mexico)

1.5.3 Europe (Germany, France, United Kingdom, Russia and Italy)

1.5.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

1.5.5 South America, Middle East & Africa

1.6 Market Dynamics

1.6.1 Market Opportunities

1.6.2 Market Risk

1.6.3 Market Driving Force

2 Manufacturers Profiles

2.1 GE Healthcare

2.1.1 GE Healthcare Details

2.1.2 GE Healthcare Major Business and Total Revenue (Financial Highlights) Analysis

2.1.3 GE Healthcare SWOT Analysis

2.1.4 GE Healthcare Product and Services

2.1.5 GE Healthcare Neurodiagnostics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

2.2 Philips Healthcare

2.2.1 Philips Healthcare Details

2.2.2 Philips Healthcare Major Business and Total Revenue (Financial Highlights) Analysis

2.2.3 Philips Healthcare SWOT Analysis

2.2.4 Philips Healthcare Product and Services

2.2.5 Philips Healthcare Neurodiagnostics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

2.3 Thermo Fisher Scientific Inc.

2.3.1 Thermo Fisher Scientific Inc. Details

2.3.2 Thermo Fisher Scientific Inc. Major Business and Total Revenue (Financial Highlights) Analysis

2.3.3 Thermo Fisher Scientific Inc. SWOT Analysis

2.3.4 Thermo Fisher Scientific Inc. Product and Services

2.3.5 Thermo Fisher Scientific Inc. Neurodiagnostics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

2.4 Siemens Healthineers

2.4.1 Siemens Healthineers Details

2.4.2 Siemens Healthineers Major Business and Total Revenue (Financial Highlights) Analysis

2.4.3 Siemens Healthineers SWOT Analysis

2.4.4 Siemens Healthineers Product and Services

2.4.5 Siemens Healthineers Neurodiagnostics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

2.5 Hitachi Ltd.

2.5.1 Hitachi Ltd. Details

2.5.2 Hitachi Ltd. Major Business and Total Revenue (Financial Highlights) Analysis

2.5.3 Hitachi Ltd. SWOT Analysis

2.5.4 Hitachi Ltd. Product and Services

2.5.5 Hitachi Ltd. Neurodiagnostics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

2.6 Canon Inc.

2.6.1 Canon Inc. Details

2.6.2 Canon Inc. Major Business and Total Revenue (Financial Highlights) Analysis

2.6.3 Canon Inc. SWOT Analysis

2.6.4 Canon Inc. Product and Services

2.6.5 Canon Inc. Neurodiagnostics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

2.7 Lifelines Neuro Company LLC

2.7.1 Lifelines Neuro Company LLC Details

2.7.2 Lifelines Neuro Company LLC Major Business and Total Revenue (Financial Highlights) Analysis

2.7.3 Lifelines Neuro Company LLC SWOT Analysis

2.7.4 Lifelines Neuro Company LLC Product and Services

2.7.5 Lifelines Neuro Company LLC Neurodiagnostics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

2.8 Natus Medical Incorporated

2.8.1 Natus Medical Incorporated Details

2.8.2 Natus Medical Incorporated Major Business and Total Revenue (Financial Highlights) Analysis

2.8.3 Natus Medical Incorporated SWOT Analysis

2.8.4 Natus Medical Incorporated Product and Services

2.8.5 Natus Medical Incorporated Neurodiagnostics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

2.9 Hoffman-La Roche AG

2.9.1 Hoffman-La Roche AG Details

2.9.2 Hoffman-La Roche AG Major Business and Total Revenue (Financial Highlights) Analysis

2.9.3 Hoffman-La Roche AG SWOT Analysis

2.9.4 Hoffman-La Roche AG Product and Services

2.9.5 Hoffman-La Roche AG Neurodiagnostics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

2.10 FUJIFILM Holdings Corporation

2.10.1 FUJIFILM Holdings Corporation Details

2.10.2 FUJIFILM Holdings Corporation Major Business and Total Revenue (Financial Highlights) Analysis

2.10.3 FUJIFILM Holdings Corporation SWOT Analysis

2.10.4 FUJIFILM Holdings Corporation Product and Services

2.10.5 FUJIFILM Holdings Corporation Neurodiagnostics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

2.11 Mitsar Co. Ltd.

2.11.1 Mitsar Co. Ltd. Details

2.11.2 Mitsar Co. Ltd. Major Business and Total Revenue (Financial Highlights) Analysis

2.11.3 Mitsar Co. Ltd. SWOT Analysis

2.11.4 Mitsar Co. Ltd. Product and Services

2.11.5 Mitsar Co. Ltd. Neurodiagnostics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

3 Sales, Revenue and Market Share by Manufacturer

3.1 Global Neurodiagnostics Sales and Market Share by Manufacturer (2018-2019)

3.2 Global Neurodiagnostics Revenue and Market Share by Manufacturer (2018-2019)

3.3 Market Concentration Rate

3.3.1 Top 3 Neurodiagnostics Manufacturer Market Share in 2019

3.3.2 Top 6 Neurodiagnostics Manufacturer Market Share in 2019

3.4 Market Competition Trend

4 Global Market Analysis by Regions

4.1 Global Neurodiagnostics Sales, Revenue and Market Share by Regions

4.1.1 Global Neurodiagnostics Sales and Market Share by Regions (2016-2020)

4.1.2 Global Neurodiagnostics Revenue and Market Share by Regions (2016-2020)

4.2 North America Neurodiagnostics Sales and Growth Rate (2016-2020)

4.3 Europe Neurodiagnostics Sales and Growth Rate (2016-2020)

4.4 Asia-Pacific Neurodiagnostics Sales and Growth Rate (2016-2020)

4.5 South America Neurodiagnostics Sales and Growth Rate (2016-2020)

4.6 Middle East and Africa Neurodiagnostics Sales and Growth Rate (2016-2020)

5 North America by Country

5.1 North America Neurodiagnostics Sales, Revenue and Market Share by Country

5.1.1 North America Neurodiagnostics Sales and Market Share by Country (2016-2020)

5.1.2 North America Neurodiagnostics Revenue and Market Share by Country (2016-2020)

5.2 United States Neurodiagnostics Sales and Growth Rate (2016-2020)

5.3 Canada Neurodiagnostics Sales and Growth Rate (2016-2020)

5.4 Mexico Neurodiagnostics Sales and Growth Rate (2016-2020)

6 Europe by Country

6.1 Europe Neurodiagnostics Sales, Revenue and Market Share by Country

6.1.1 Europe Neurodiagnostics Sales and Market Share by Country (2016-2020)

6.1.2 Europe Neurodiagnostics Revenue and Market Share by Country (2016-2020)

6.2 Germany Neurodiagnostics Sales and Growth Rate (2016-2020)

6.3 UK Neurodiagnostics Sales and Growth Rate (2016-2020)

6.4 France Neurodiagnostics Sales and Growth Rate (2016-2020)

6.5 Russia Neurodiagnostics Sales and Growth Rate (2016-2020)

6.6 Italy Neurodiagnostics Sales and Growth Rate (2016-2020)

7 Asia-Pacific by Regions

7.1 Asia-Pacific Neurodiagnostics Sales, Revenue and Market Share by Regions

7.1.1 Asia-Pacific Neurodiagnostics Sales and Market Share by Regions (2016-2020)

7.1.2 Asia-Pacific Neurodiagnostics Revenue and Market Share by Regions (2016-2020)

7.2 China Neurodiagnostics Sales and Growth Rate (2016-2020)

7.3 Japan Neurodiagnostics Sales and Growth Rate (2016-2020)

7.4 Korea Neurodiagnostics Sales and Growth Rate (2016-2020)

7.5 India Neurodiagnostics Sales and Growth Rate (2016-2020)

7.6 Southeast Asia Neurodiagnostics Sales and Growth Rate (2016-2020)

7.7 Australia Neurodiagnostics Sales and Growth Rate (2016-2020)

8 South America by Country

8.1 South America Neurodiagnostics Sales, Revenue and Market Share by Country

8.1.1 South America Neurodiagnostics Sales and Market Share by Country (2016-2020)

8.1.2 South America Neurodiagnostics Revenue and Market Share by Country (2016-2020)

8.2 Brazil Neurodiagnostics Sales and Growth Rate (2016-2020)

8.3 Argentina Neurodiagnostics Sales and Growth Rate (2016-2020)

9 Middle East & Africa by Countries

9.1 Middle East & Africa Neurodiagnostics Sales, Revenue and Market Share by Country

9.1.1 Middle East & Africa Neurodiagnostics Sales and Market Share by Country (2016-2020)

9.1.2 Middle East & Africa Neurodiagnostics Revenue and Market Share by Country (2016-2020)

9.2 Saudi Arabia Neurodiagnostics Sales and Growth Rate (2016-2020)

9.3 Turkey Neurodiagnostics Sales and Growth Rate (2016-2020)

9.4 Egypt Neurodiagnostics Sales and Growth Rate (2016-2020)

9.5 South Africa Neurodiagnostics Sales and Growth Rate (2016-2020)

10 Market Segment by Product

10.1 Global Neurodiagnostics Sales and Market Share by Product (2016-2020)

10.2 Global Neurodiagnostics Revenue and Market Share by Product (2016-2020)

10.3 Global Neurodiagnostics Price by Product (2016-2020)

11 Global Neurodiagnostics Market Segment by Condition

11.1 Global Neurodiagnostics Sales Market Share by Condition (2016-2020)

11.2 Global Neurodiagnostics Revenue Market Share by Condition (2016-2020)

11.3 Global Neurodiagnostics Price by Condition (2016-2020)                                                              

12 Global Neurodiagnostics Market Segment by End User

12.1 Global Neurodiagnostics Sales Market Share by End User (2016-2020)

12.2 Global Neurodiagnostics Revenue Market Share by End User (2016-2020)

12.3 Global Neurodiagnostics Price by End User (2016-2020)

13 Market Forecast

13.1 Global Neurodiagnostics Sales, Revenue and Growth Rate (2021-2024)

13.2 Neurodiagnostics Market Forecast by Regions (2021-2024)

13.2.1 North America Neurodiagnostics Market Forecast (2021-2024)

13.2.2 Europe Neurodiagnostics Market Forecast (2021-2024)

13.2.3 Asia-Pacific Neurodiagnostics Market Forecast (2021-2024)

13.2.4 South America Neurodiagnostics Market Forecast (2021-2024)

13.2.5 Middle East & Africa Neurodiagnostics Market Forecast (2021-2024)

13.3 Neurodiagnostics Market Forecast by Type (2021-2024)

13.3.1 Global Neurodiagnostics Sales Forecast by Type (2021-2024)

13.3.2 Global Neurodiagnostics Market Share Forecast by Type (2021-2024)

13.4 Neurodiagnostics Market Forecast by Application (2021-2024)

13.4.1 Global Neurodiagnostics Sales Forecast by Application (2021-2024)

13.4.2 Global Neurodiagnostics Market Share Forecast by Application (2021-2024)

14 Sales Channel, Distributors, Traders and Dealers

14.1 Sales Channel

14.1.1 Direct Marketing

14.1.2 Indirect Marketing

14.2 Distributors, Traders and Dealers

15 Research Findings and Conclusion

16 Appendix

16.1 Methodology

16.2 Data Source

16.3 Disclaimer

16.4 About US

 

Reason to Buy

  • Current and future of Medical Devices & Consumables Market outlook in the developed and emerging markets
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The segment that is expected to dominate the Medical Devices & Consumables Market
  • Regions that are expected to witness the fastest growth during the forecast period
  • Identify the latest developments, Medical Devices & Consumables Market shares, and strategies employed by the major market players
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Medical Devices & Consumables Market
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets